Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4551840
Max Phase: Preclinical
Molecular Formula: C6H13NO5
Molecular Weight: 179.17
Molecule Type: Unknown
Associated Items:
ID: ALA4551840
Max Phase: Preclinical
Molecular Formula: C6H13NO5
Molecular Weight: 179.17
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3+,4-,5-,6?/m1/s1
Standard InChI Key: MSWZFWKMSRAUBD-CBPJZXOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 179.17 | Molecular Weight (Monoisotopic): 179.0794 | AlogP: -3.25 | #Rotatable Bonds: 1 |
Polar Surface Area: 116.17 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.73 | CX Basic pKa: 8.23 | CX LogP: -3.04 | CX LogD: -3.93 |
Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.29 | Np Likeness Score: 2.14 |
1. (2014) Fibcd1 for the prevention and treatment of diseases, |
Source(1):